The IL-33/ST2 Pathway in Cerebral Malaria.

Int J Mol Sci

Center for Infection and Immunity of Lille-CIIL, Institut Pasteur de Lille, CNRS UMR 9017-Inserm U1019, University Lille, 59019 Lille, France.

Published: November 2022

AI Article Synopsis

Article Abstract

Interleukin-33 (IL-33) is an immunomodulatory cytokine which plays critical roles in tissue function and immune-mediated diseases. IL-33 is abundant within the brain and spinal cord tissues where it acts as a key cytokine to coordinate the exchange between the immune and central nervous system (CNS). In this review, we report the recent advances to our knowledge regarding the role of IL-33 and of its receptor ST2 in cerebral malaria, and in particular, we highlight the pivotal role that IL-33/ST2 signaling pathway could play in brain and cerebrospinal barriers permeability. IL-33 serum levels are significantly higher in children with severe malaria than children without complications or noninfected children. IL-33 levels are correlated with parasite load and strongly decrease with parasite clearance. We postulate that sequestration of infected erythrocytes or merozoites liberation from schizonts could amplify IL-33 production in endothelial cells, contributing either to malaria pathogenesis or recovery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658244PMC
http://dx.doi.org/10.3390/ijms232113457DOI Listing

Publication Analysis

Top Keywords

cerebral malaria
8
il-33
6
il-33/st2 pathway
4
pathway cerebral
4
malaria
4
malaria interleukin-33
4
interleukin-33 il-33
4
il-33 immunomodulatory
4
immunomodulatory cytokine
4
cytokine plays
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!